In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...

Conditional immune adverse event rate in urothelial and renal cell carcinoma patients treated with immune checkpoint inhibitors. Outcomes of patients with high-risk non-muscle invasive bladder cancer ...

At age 57, a senior scientific researcher in Santa Barbara, California, complained of chronic erectile dysfunction (ED) in what had been a sexually active marriage. "I just couldn't get an erection, ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Read the full article PDF by clicking here or on the link below.

Are you a member of an institution such as a university or hospital?Learn more about Institutional Access ...

Racial disparities in stage IV prostate cancer outcomes in the Veterans Affairs hospital system. Cardiovascular events and clinical responses in prostate cancer patients treated with transcutaneous ...

The field of regenerative medicine continues to make substantial advancements in therapeutic strategies addressing urologic diseases. Tissue engineering borrows principles from the fields of cell ...

Researchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called "myeloid mimicry" to hide from the immune system ...